Quarterly Earnings

The children's apparel giant posts strong Q4 sales, but steep tariff impacts and strategic spending lead to a forecast of declining earnings per share.

After a challenging year, InTest Corp. posts a strong Q4 rebound, driven by growth in non-semi markets. A robust backlog signals a promising 2026.

After a 25-year era of global growth, Lansinoh appoints Julie Talbot to redefine parental support and scale a new, empathetic vision worldwide.

As Roblox's CFO prepares for a key conference, investors seek clarity on profitability, metaverse strategy, and a competitive digital future.

Post-acute leader PACS Group reports a landmark year with a 29% revenue jump, fueled by superior patient care metrics and a disciplined expansion strategy.

With its Healthcare Services platform growing, SelectQuote executives will face investors to detail their tech-driven strategy amid market pressures.

Sysco's latest dividend declaration offers more than shareholder returns; it provides a key signal on the health of the global food service industry.

The diagnostics firm topped revenue forecasts with explosive growth in core tests, navigating a net loss with a strategic pivot into new markets.

Clipper Realty's Q4 results show a stark divide in NYC real estate, as soaring apartment rents struggle to offset deep losses from its troubled office portfolio.

As Acorn preps its Q4 results, we look at the microcap's macro impact on grid reliability, cell towers, and the burgeoning smart energy market.

NextPlat's Orbital Satcom enters five LATAM markets via e-commerce giant Mercado Libre, aiming to connect millions in a region hungry for satellite tech.

The burger chain posted robust revenue and a massive jump in annual net income, outperforming rivals and detailing plans for major global expansion.

With a key FDA decision looming and pivotal data on a second therapy imminent, Viridian is poised to reshape the multi-billion dollar Thyroid Eye Disease market.

The hydration giant posts a 29% revenue jump to $6.7B in its first year, signaling a strong start, but focuses on fixing customer service snags.

With its strategic pivot to high-growth Med Tech paying off, all eyes are on AngioDynamics' CEO presentation at the upcoming Leerink healthcare conference.

The environmental services giant surpassed 2025 targets, driven by its GreenUp strategy, major acquisitions in water tech, and a renewed global push.

After a year focused on organic growth, the environmental firm posted record results and now plans a disciplined return to acquisitions in 2026.

PROCEPT BioRobotics reports record Aquablation procedures but lowers 2026 revenue guidance, signaling a strategic shift for long-term profitability.

The biopharma company shatters records with 51% growth in its key drug, ASCENIV, and outlines a strategic overhaul aimed at long-term market dominance.

Amid record financials and new AI breakthroughs, Cadence's CEO will address investors at a key conference to outline the firm's pivotal role in the AI era.